HIGHLIGHTS
- who: Bertrand Tchana and Carlo Caffarelli from the Pediatric Cardiology Division, Parma General and University Hospital, Parma, Italy have published the Article: Inhaled Short-Acting Beta Agonist Treatment-Associated Supraventricular Tachycardia in Children: Still a Matter of Concern in Pediatric Emergency Departments?, in the Journal: Children 2023, 699 of 31/Dec/2022
- what: Cardiovascular events including supraventricular arrhythmias are the most frequent side effects reported with inhaled SABA in children with asthma and are the main reason for a continuing debate about their safety despite their widespread use. In children, acute exacerbations of asthma are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.